Penny Heaton, M.D., is the Global Therapeutic Area Head for Infectious Diseases & Vaccines at Janssen Research & Development, L.L.C. In this role, she leads a global team focused on developing transformational vaccines to prevent some of the most devastating infectious diseases the world faces today.
Anthony Fernandez is the Worldwide Vice President, Infectious Diseases and Vaccines, Global Commercial Strategy Organization. In this role, Anthony is responsible for leading Janssen’s global commercial efforts to build and maximize the value of the ID&V portfolio and pipeline in areas of high unmet needs, including HIV, hepatitis B and D, respiratory syncytial virus (RSV), influenza, and multi-drug resistant infections. He has oversight of Strategic Marketing, Market Access, Medical Affairs, and Strategic Analytics resources dedicated to the therapeutic area.